✦ LIBER ✦

Combination of irinotecan and bevacizumab for heavily pretreated recur- rent ovarian cancer: A phase II trial

✍ Scribed by Ling, H.; Muggia, F.; Speyer, J.; Curtin, J.; Blank, S.; Boyd, L.; Pothuri, B.; Li, X.; Goldberg, J.; Tiersten, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of irofulven in women w

✍ Michael V. Seiden; Alan N. Gordon; Diane C. Bodurka; Ursula A. Matulonis; Richar 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 112 KB

6049 Phase II trial of combined chemothe

✍ Hatanaka, K.; Komatsu, Y.; Yuki, S.; Nakamura, M.; Miyagishima, T.; Kudo, M.; Mu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Combining capecitabine, oxaliplatin, and

✍ Se Hyun Kim; Sang Joon Shin; Sun Young Kim; Se Hoon Lee; Young Suk Park; Se Hoon 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 300 KB

A phase II trial of a paclitaxel and oxa

✍ Viens, P.; Bougnoux, P.; Rixe, O.; Petit, T.; Laadem, A.; Cottu, P.; Delva, R.; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 186 KB

A phase II trial of weekly fractionated

✍ Hei-Cheul Jeung; Sun Young Rha; Sung Hoon Noh; Jae Kyung Roh; Hyun Cheol Chung 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 308 KB

Phase II randomized trial of bevacizumab

✍ George Somlo; Ashkan Lashkari; William Bellamy; Todd M. Zimmerman; Joseph M. Tus 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB